A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity
Evaluation of local control and acute and late toxicity regarding a hypofractionated RT schedule for breast cancer patients.
Methods and Materials
Between October 2007 and October 2009, 80 women with early breast cancer were treated by 42.75 Gy in 15 fractions over 5 weeks. This treatment involved three fractions per week (Monday–Wednesday–Friday). All patients received an additional boost dose to the tumor bed of 8.55 Gy in 3 fractions using 6 MV photons. The primary endpoint included any local recurrence in the treated breast. Secondary endpoint included acute and late radiation skin toxicity. The median follow-up time was 63 months (range 60–72). Radiation toxicity was graded according the RTOG/EORTC criteria.
Neither local nor distant recurrence was noted in any patient during this 3-year follow-up. Grade 0, 1, 2 acute skin toxicity was observed in 56/80 (70.0 %), in 19/80 (23.8 %) and in 5/80 (6.3 %), respectively. Three months post-RT, toxicity grades 0, 1, 2 skin toxicity were 64/80 (80 %), 14/80 (17.5 %) and 2/80 (2.5 %), respectively. Late toxicity as grade 0, 1 was observed in 72/80 (90.0 %) and in 8/80 (10.0 %), respectively, 6 months post-RT, whereas after 1 year they were 78/80 (97.5 %) and 2/80 (2.5 %), respectively.
Preliminary results regarding skin reactions, cosmetic appearance and local control are consistent with published data that support the use of shorter fractionation schedules in early breast cancer patients after breast conservative surgery. Longer follow-up and a randomized prospective study stand in need for the extraction of safe conclusions.
KeywordsHypofractionation Radiotherapy Breast cancer Toxicity
- 4.Jones B, Dale RG, Deehan K, Hopkins KI, Morgan DAL. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol. 2001;13:71–81.Google Scholar
- 16.Yarnold J, Bloomeld D, LeVay J. Prospective randomized trial testing 5.7 Gy and 6.0 Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol. 2004;16:S30.Google Scholar
- 17.The START ‘Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;29:1098–107.Google Scholar
- 19.International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy, ICRU report 50. Bethesda: International Commission on Radiation Units and Measurements; 1993. p. 3–16.Google Scholar
- 20.International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy, ICRU report 62. Bethesda: International Commission on Radiation Units and Measurements; 1999.Google Scholar
- 25.Thrapsanioti Z, Karanasiou I, Platoni K, et al. Transformation of physical DVHs to radiobiologically equivalent ones in hypofractionated radiotherapy analyzing dosimetric and clinical parameters: a practical approach for routine clinical practice in radiation oncology. Comput Math Methods Med. 2013;2013:713420. doi:10.1155/2013/713420.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10 year follow-up results of two 17 randomized controlled trials. Lancet Oncol. 2013;14(11):1086–94.CrossRefPubMedGoogle Scholar
- 33.Agrawal RK, Alhasso A, Barrett-Lee PJ, et al. First results of the 17randomized UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol. 2011;100(1):93e100.Google Scholar